The FDA has entered an agreement with healthcare analytics company Aetion to research urgent questions about COVID-19. The New York City-based company said the research will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns using relevant, novel data sources and analyzing these data according to […]
Aetion
Sanofi, Aetion collaborate to advance regulatory submissions
Sanofi (NYSE:SNY) announced today that it entered into a collaboration with Aetion to integrate its Darwin data platform with the Aetion Evidence platform to try and advance the efficiency of real-world evidence. The collaboration between the two companies will set out to facilitate regulatory-grade studies with deep transparency while opening access to new real-world data, according […]